Literature DB >> 28002820

Zika Virus Infection in the Elderly: Possible Relationship with Guillain-Barré Syndrome.

Wilson Savino1, Carolina V Messias, Daniella A Mendes-da-Cruz, Pamela Passos, Ana Carolina A F Ferreira, Osvaldo J Nascimento.   

Abstract

The Zika virus (ZIKV) outbreak in French Polynesia, in 2013, and in Brazil, in 2015, was correlated with neurological complications, which comprised, among others, congenital microcephaly and Guillain-Barré syndrome (GBS), which includes a group of acute autoimmune neuropathies generally reported after respiratory or gastrointestinal infectious diseases. Despite being relatively rare, the incidence rate of GBS rises with age, which makes GBS more frequent in the elderly, in whom it is also a more severe disease with slower recovery than in younger patients. Different forms of GBS have been described having diagnostic confirmation of a previous infection with the ZIKV virus. Although we do not have enough evidence that elderly people are a particularly susceptible population to developing GBS following ZIKV infection, this is plausible. We should consider this possibility, particularly taking into account that aging subjects are more susceptible to infections. In this context, a deeper understanding of how the immune system in the elderly functions in relation to ZIKV infection is necessary, as well as an understanding of what kind of alterations of the nervous system such an infection triggers in the elderly, beyond GBS. This will be relevant for better therapeutic interventions and for designing vaccine candidates that can be applied in an aging population, particularly those prone to develop ZIKV-induced autoimmunity.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 28002820     DOI: 10.1159/000453579

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  6 in total

Review 1.  Zika Virus: An Emerging Global Health Threat.

Authors:  Rahul Mittal; Desiree Nguyen; Luca H Debs; Amit P Patel; George Liu; Vasanti M Jhaveri; Sae-In S Kay; Jeenu Mittal; Emmalee S Bandstra; Ramzi T Younis; Prem Chapagain; Dushyantha T Jayaweera; Xue Zhong Liu
Journal:  Front Cell Infect Microbiol       Date:  2017-12-08       Impact factor: 5.293

2.  Zika virus infection in the Veterans Health Administration (VHA), 2015-2016.

Authors:  Patricia L Schirmer; Aaron Wendelboe; Cynthia A Lucero-Obusan; Russell A Ryono; Mark A Winters; Gina Oda; Mirsonia Martinez; Sonia Saavedra; Mark Holodniy
Journal:  PLoS Negl Trop Dis       Date:  2018-05-24

3.  Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise.

Authors:  Wanbo Tai; Denis Voronin; Jiawei Chen; Weili Bao; Debra A Kessler; Beth Shaz; Shibo Jiang; Karina Yazdanbakhsh; Lanying Du
Journal:  Front Microbiol       Date:  2019-01-23       Impact factor: 5.640

4.  Zika virus targets the human thymic epithelium.

Authors:  Carolina V Messias; Guilherme Loss-Morais; Joseane Biso de Carvalho; Mariela N González; Daniela P Cunha; Zilton Vasconcelos; Luis W P Arge; Désio A Farias-de-Oliveira; Alexandra L Gerber; Elyzabeth A Portari; Nilma Ferreira; Lidiane M S Raphael; Myrna C Bonaldo; Ingo Riederer; Maria E Lopes Moreira; Vinicius Cotta-de-Almeida; Ana T R Vasconcelos; Daniella A Mendes-da-Cruz; Wilson Savino
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

5.  In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.

Authors:  Ana Clara Barbosa Antonelli; Vinnycius Pereira Almeida; Fernanda Oliveira Feitosa de Castro; Jacyelle Medeiros Silva; Irmtraut Araci Hoffmann Pfrimer; Edecio Cunha-Neto; Andréa Queiroz Maranhão; Marcelo Macedo Brígido; Renato Oliveira Resende; Anamélia Lorenzetti Bocca; Simone Gonçalves Fonseca
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  Point-of-care diagnostic assay for the detection of Zika virus using the recombinase polymerase amplification method.

Authors:  Nadina I Vasileva Wand; Laura C Bonney; Robert J Watson; Victoria Graham; Roger Hewson
Journal:  J Gen Virol       Date:  2018-06-13       Impact factor: 3.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.